Watchlist Price Alert

Neuronetics Inc. (STIM)

NASDAQ: STIM · Real-Time Price · USD

3.65

-0.14 (-3.69%)

At close: Jun 16, 2025, 3:59 PM

3.83

4.79%

After-hours: Jun 16, 2025, 06:45 PM EDT

-3.69% (1D)

Bid	3.61
Market Cap	240.57M
Revenue (ttm)	89.45M
Net Income (ttm)	-48.01M
EPS (ttm)	-1.32
PE Ratio (ttm)	-2.77
Forward PE	-21.19
Analyst	Buy

Ask	3.84
Volume	304,805
Avg. Volume (20D)	845,076
Open	3.85
Previous Close	3.79
Day's Range	3.65 - 3.90
52-Week Range	0.52 - 5.92
Beta	1.92

About STIM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol STIM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for STIM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

+0%

Neuronetics shares are trading lower after the com... Unlock content with Pro Subscription

3 months ago

+7.11%

Neuronetics shares are trading higher after Citizens JMP and Canaccord raised their respective price targets on the stock.

News

1 month ago · seekingalpha.com

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

Neuronetics, Inc. (NASDAQ:STIM ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Mark Klausner - Investor Relations Keith Sullivan - President & Chief Executive Officer St...

1 month ago · zacks.com

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics (STIM) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.27 per share a year ago.

2 months ago · seekingalpha.com

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Neuronetics has shown significant growth, with a 430% rally since November and strong Q4 2024 results, driven by its NeuroStar TMS therapy system. The company's valuation remains attractive despite re...

3 months ago · zacks.com

Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet

The mean of analysts' price targets for Neuronetics (STIM) points to a 35% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys...